UnknownNot Applicable

Cavernous Tissue Preservation During Penile Prosthesis Implantation

Egypt100 participantsStarted 2018-11-01

Plain-language summary

Spontaneous penile tumescence after penile prosthesis implantation has been previously reported as sporadically occurring during implant surgery. This study aims at systematically preserving residual erectile function, by the preservation of the patients' spontaneous penile tumescence by systematically sparing cavernous tissue during penile prosthesis implantation.

Who can participate

Age range18 Years – 81 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Erectile dysfunction not amenable to treatment by approved medical therapy Exclusion Criteria: * Erectile dysfunction amenable to treatment by approved medical therapy

What they're measuring

Cavernous tissue thickness postoperatively measured by ultrasound

Timeframe: 1 month

Trial details

NCT IDNCT03733860

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

View on ClinicalTrials.gov More Erectile Dysfunction trials